Stock Research: Max Healthcare Institute

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Max Healthcare Institute

BSE:543220 INE027H01010
10
  • Value
    27
  • Growth
    91
  • Safety
    Safety
    1
  • Combined
    18
  • Sentiment
    23
  • 360° View
    360° View
    10
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Max Healthcare Institute Limited is an India-based integrated healthcare provider specializing in advanced cardiac care, orthopedics, oncology, neurosciences, and more, also offering outpatient and diagnostic services through Max Lab and Max@Home. It operates across Delhi NCR, Haryana, Punjab, Uttarakhand, Maharashtra, and Uttar Pradesh. In the last fiscal year, the company had 15114 employees, a market cap of $14319 million, profits of $636 million, and revenue of $823 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 10 (better than 10% compared with alternatives), overall professional sentiment and financial characteristics for the stock Max Healthcare Institute are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Max Healthcare Institute. The consolidated Growth Rank has a good rank of 91, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. It ranks higher than 91% of competitors in the same industry. The other indicators are below average, namely the Value, Safety, and Sentiment Ranks.The Value Rank at 1 means that the share price of Max Healthcare Institute is on the high side compared with its peers regarding revenues, profits, and invested capital. The stock price is higher than for 99% of alternative stocks in the same industry. The consolidated Safety Rank has a riskier rank of 27, which means that the company has a riskier financing structure than 73% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. The consolidated Sentiment Rank also has a low rank of 23, indicating professional investors are more pessimistic about the stock than for 77% of alternative investment opportunities. ...read more

more
Index
Moonshot Tech
Robotics
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
1 3 6 7
Growth
91 79 97 99
Safety
Safety
27 46 58 24
Sentiment
23 55 63 32
360° View
360° View
10 34 67 21
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
47 53 59 100
Opinions Change
22 43 59 50
Pro Holdings
n/a 74 39 1
Market Pulse
52 66 74 33
Sentiment
23 55 63 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
1 3 6 7
Growth
91 79 97 99
Safety Safety
27 46 58 24
Combined
18 26 65 32
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
5 7 12 22
Price vs. Earnings (P/E)
4 3 7 17
Price vs. Book (P/B)
11 12 24 26
Dividend Yield
18 14 12 1
Value
1 3 6 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
94 94 89 53
Profit Growth
90 65 44 100
Capital Growth
28 27 95 91
Stock Returns
91 81 89 100
Growth
91 79 97 99
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
41 52 68 60
Refinancing
16 11 23 17
Liquidity
50 72 61 16
Safety Safety
27 46 58 24

Similar Stocks

Discover high‑ranked alternatives to Max Healthcare Institute and broaden your portfolio horizons.

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

L&T Finance Holdings

BSE:533519
Country: India
Industry: Other Financial Services
Size: Medium
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.